0:03
Hello and welcome to ACR Convergence coverage here on RheumNow.
0:08
I'm Eric Dy from Summit, New Jersey. I'm joined by Dr. Dam Sean from the Myositis Division at Rush, and I'm here today to talk to you about abstract 2825. Tell me a little bit about your study.
0:22
So again, I'm Dam Sean. I'm a myositis clinical researcher from Rush.
0:28
In the study we have conducted an electronic survey, cross-sectional survey study, where patients with myositis — about 552 patients with myositis who report pain attributable to myositis — responded to the survey.
0:42
Our goal was to understand the characteristics of pain in these patients.
0:47
Pain was just thought to not actually be prominent in myositis.
0:53
It was long believed to be a painless disease.
0:58
So this is really taking that step forward, saying that this is common, and now we're trying to understand the characteristics of pain in these people.
1:05
And so when you're studying for the boards it usually will say painless disorder.
1:09
How many of these patients did you find have pain?
1:12
Yes. So in several different studies that we've done, approximately 70% of patients with myositis report pain that's significant enough to interfere with their daily activities.
1:26
In some cohorts this number goes up to 86%, and in some of them it is lower, about 65%, but in general it seems like the majority of patients with myositis report pain.
1:37
And so tell me about how did you find the patients for the study and how did you ask them questions?
1:41
Yes. So this was an electronic survey and we've collaborated with two patient organizations to distribute the survey.
1:50
One was the TMA, the Myositis Association — that's the largest patient organization — as well as the MSU, the Myositis Support and Understanding group.
1:59
They have their listservs, they have several social media platforms that they actively use, and they have advertised and circulated our survey on these platforms.
2:09
And were you able to get a little bit more information about the type of pain — you know, how they describe this pain in myositis?
2:16
Yes. So that was our goal. We asked the patients, first of all, do you feel this more in the morning, more in the evening, how does it change during the day?
2:28
We saw that that was quite variable — some people reported being worse in the morning, some in the evening, some it's about the same.
2:34
So that was one diurnal variation that we asked people about.
2:39
And then also we asked, is this a pain that kind of comes and goes, or is it persistent?
2:44
And the majority — over 70% of patients — said this is a persistent pain that's there all the time.
2:50
Was there a difference between myositis subgroups?
2:53
Yeah, that is a good question. So overlap myositis — the patients with myositis who also meet criteria for other autoimmune diseases — had the highest levels of pain, and patients with inclusion body myositis had the lowest levels of pain.
3:11
And one of the things I found interesting about your study was that you had not just quantitative but also qualitative information, and patients were able to provide really detailed information.
3:26
Tell me a little bit about how you were able to understand that qualitative information.
3:30
Yeah. So we had two questions in the survey where we asked the patients a free-text question: how do you know that this pain is coming from your myositis and not from something else?
3:43
That was one free-text question, because we really did not want to give them choices and bias them in any way.
3:48
It's a new concept and we wanted to learn as much as we can.
3:53
And then the other question we asked was: what makes your pain better and what makes your pain worse, in your opinion?
3:59
So the way we analyzed this data — initially we really didn't expect to get this many responses to our survey, so we were going to do a qualitative analysis.
4:10
But given that we had over 500 responses and all of them had answers to the free-text question, we actually used large language models — ChatGPT — and we asked it to create themes as well as representative quotes from each theme as an answer to that question.
4:27
So this is an exploratory approach obviously, but I think it's going to be developed and used more and more commonly in the rheumatology field.
4:33
Yeah, and probably very nice to have some of that more detail with the free-text responses rather than just checking boxes. Yes.
4:43
I think this was a really wonderful study.
4:46
Presumably, with it being a survey, there may be a little bit of survey bias, but I think it does really help bridge some of that gap.
4:53
I have a lot of patients who feel almost like they're being gaslit when they're told that their myositis shouldn't be painful and they're experiencing pain.
5:00
Exactly. Yes, we hear that a lot from the patients.
5:06
They say that they do not feel like their pain is well understood by their care team.
5:11
And hopefully this study again takes this question from how common is it, to what kind of pain these patients are experiencing.
5:17
And hopefully we have some other posters also at this ACR trying to understand what's driving this pain — is it more of a fibromyalgia-like nociplastic pain, is it more of a mechanical pain, or is it inflammation-driven pain?
5:32
So once we understand the mechanisms better, hopefully we will be able to develop specific treatment and management strategies for these patients.
5:40
Thank you very much. I appreciate you educating us on this topic.
5:45
And for more information on ACR Convergence coverage, tune in to RheumNow for more. Thank you for having me. Thank you.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.